Navigation Links
China Medical Technologies to Participate in Credit Suisse's 2007 Asian Technology Conference
Date:9/3/2007

BEIJING, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in- vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announced that it will participate in Credit Suisse's 2007 Asian Technology Conference - China Day.

Location: Shenzhen, China

Date: September 10, 2007

China Medical Technologies' management team will discuss the Company's strategy, operations and growth opportunities, as well as its published results to date with securities analysts and institutional portfolio managers.

Please contact Credit Suisse for more information about the conference.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .

For more information, please contact:

China Medical Technologies, Inc.

Winnie Fan

Tel: +86-10-6530-8833

Email: IR@chinameditech.com


'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. How do you level the playing field with China?
2. Medical College receives $377K to study brain disease
3. Barriers will not stop convergence of medical technologies
4. Medical College team creates website for tracking flu
5. Biomedical engineering conference invites manufacturers
6. Visions: Wade offers straight talk on e-medical records
7. Merge unveils updated medical imaging software
8. Medical College receives $1.4M cancer grant
9. Medical technology firm lands $100K federal grant
10. Doyle outlines spending for Medical College, UWM
11. And the winners in medical design are

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Y,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHeal...,GenomicHealth,sExecutiveChairman,willpresentatthe...kCityonTuesday,December1,2009at10:00a.m.ET. ,, ...presentation,visittheInvestorRelationssectionofGen...h.com .Pleaseconnecttothewebsiteatleast15minutespr...
(Date:11/23/2009)... Nov. 23, 2009 In a provocative new study, a Univ... dioxide emissions the major cause of global warm...my collapses or society builds the equivalent of o...s unlikely that there will be any substantial near...n in carbon dioxide emission rates," says the new ...
(Date:11/23/2009)...A,ON,Nov.23/PRNewswire-FirstCall/-YMBioSciencesInc...opmentcompanythatidentifiesandadvancesadiverseport...gesofdevelopment,todayreportedthatCytopia(ASX:CYT)...YT387,apotent,orally-administeredJAK1/JAK2inhibito...Minnesota.AproposaltomergeCytopiaintoYMhasbeenprev...
(Date:11/23/2009)...EW,Calif.,Nov.23/PRNewswire/--Frost&Sullivan,t...iesfordemonstratingleadershipandinnovationThursday...ionAwardsBanquetheldinSanAntonio,Texas. ,, (Log...LOGO ) ,, TheHealthcareInnovationAwardsaregiven...hedeliveryandmanagementofhealthcare.Suchcompaniesh...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3
...ISON - EraGen Biosciences , announced today they ...edico , Canada,s leading independent distributor o...The announcement follows the companys distribution..., ,"Both companies share the same goal; to create ... customer value. Inter Medico,s highly skilled tea...
...ective April 14, 2004, the privacy rules under the...ct of 1996 (HIPAA) generally apply to all health p...nder $5,000,000. , , What is a health plan? , ,...that provides medical care. Examples of health pl...ion plans, employee assistance plans (EAPs) that p...
...e you ever received e-mail with attachments contai...for you? Whether these documents were sent in erro... a disgruntled employee, the consequences can be e...s and breaches of national security may result fro...t DEMO 2004 conference, Adobe Systems recently int...
Other Biology Technology:Time for health plans to comply with HIPAA privacy rules 2Time for health plans to comply with HIPAA privacy rules 3New solution protects corporate information 2
(Date:11/24/2009)... Rocket science is opening new doors to understan...ffect the hearing of a marine mammal or if they h...al sized X-ray scanners that NASA uses to detect f...ckets is now allowing scientists to peek inside th...etailed three-dimensional replicas of a whale,s he...
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fr...r six months, those stents are no longer needed --...nnecessary. Previously, doctors had no choice but ... of Tel Aviv University,s Department of Biomedical...ber platform that carries drugs where they,re need...
(Date:11/24/2009)... Springer and the American College of Medical Tox...rate on the publication of the Journal of Medical...MT, beginning in March 2010. It was previously pu..., The Journal of Medical Toxicology , an intern...vancing the science and practice of medical toxico...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2A coating for life 2Springer and the American College of Medical Toxicology to work together 2Ruben Studdard American Idol Winner and R 26B Pop Star Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 49226 1Ruben Studdard American Idol Winner and R 26B Pop Star Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 49226 2Ruben Studdard American Idol Winner and R 26B Pop Star Spreads the Word about Sickle Cell Disease and the Dangers of Iron Overload 49226 3Aflac Again Honored as One of the 100 Best Places to Work in IT 49224 1Aflac Again Honored as One of the 100 Best Places to Work in IT 49224 2Aflac Again Honored as One of the 100 Best Places to Work in IT 49224 3BD and FIND Achieve Milestone in Global Battle Against MDR TB 12675 1BD and FIND Achieve Milestone in Global Battle Against MDR TB 12675 2BD and FIND Achieve Milestone in Global Battle Against MDR TB 12675 3BD and FIND Achieve Milestone in Global Battle Against MDR TB 12675 4
... raise the risk of mother-to-child transmission of...dies published in the December 1 issue of The Jour... , One study found that infant girls are twice as ...s provide new information with which to counsel pr...e two new studies expand upon preliminary data fro...
...ists at the University of California, Berkeley, ha...in reaction that leads to the increased expression...m. , The new findings, to be published July 3 in a... long-standing question of how the natural killer ... differentiate cells that are cancerous from those...
...hool of Medicine have found that 85 percent of emb...l to become live births, highlighting the need for...e embryos. , Published in the August issue of Fert...s of U.S. statistics from all the fertility clinic...ector of the Yale Fertility Center, Pasquale Patri...
Other Biology News:Studies clarify risk factors for mother-to-child transmission of hepatitis C virus 2New study finds how cells with damaged DNA alert the immune system 2New study finds how cells with damaged DNA alert the immune system 3
Mouse Anti-Human HLA II DG+DR+DP Monoclonal Antibody, Unconjugated, Clone IQU9 from Diaclone
Duck Anti-Phenytoin-BSA Antibody, Unconjugated from Good Biotech Corp
Anti-Tropomyosin 4 Antibody, Unconjugated from CHEMICON
Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4 from Abcam
Biology Products: